Clinical Trial Update: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating panobinostat with stereotactic radiation therapy for brain tumors, including recurrent glioma, high-grade meningioma, and brain metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastasis
• Glioma
• Meningioma

Drugs mentioned

• Panobinostat (Farydak) (panobinostat)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Recurrent Glioma, High-grade Meningioma | Phase 1 | Status: TERMINATED